AllCourtTENNIS
Explorer
Marketwatch ran a fairly lengthy piece looking at the corporate contest between Novo and Lilly. Since this outlet limits you to 1 free article each month, I've included a pdf as well.
https://www.marketwatch.com/story/how-ozempic-maker-novo-nordisk-blew-its-lead-in-glp-1-weight-loss-drugs-can-europe-compete-in-the-high-stakes-global-economy-0a2bcfd0?mod=home_lead
https://www.marketwatch.com/story/how-ozempic-maker-novo-nordisk-blew-its-lead-in-glp-1-weight-loss-drugs-can-europe-compete-in-the-high-stakes-global-economy-0a2bcfd0?mod=home_lead